MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $392,409 | -13.6% | 2,687 | +36.7% | 0.29% | -14.2% |
| Q2 2023 | $454,146 | +27.2% | 1,966 | +33.4% | 0.34% | +58.2% |
| Q1 2023 | $357,091 | +20.4% | 1,474 | +44.2% | 0.21% | -16.1% |
| Q4 2022 | $296,636 | -99.9% | 1,022 | -73.5% | 0.25% | -1.6% |
| Q3 2022 | $250,341,000 | +90933.1% | 3,852 | +37.5% | 0.26% | +47.4% |
| Q1 2022 | $275,000 | +22.2% | 2,801 | +5.5% | 0.18% | +31.6% |
| Q4 2021 | $225,000 | -5.1% | 2,656 | -10.8% | 0.13% | -13.1% |
| Q3 2021 | $237,000 | +3.0% | 2,976 | +26.2% | 0.15% | +21.4% |
| Q2 2021 | $230,000 | -14.8% | 2,358 | +2.1% | 0.13% | -21.7% |
| Q1 2021 | $270,000 | +31.7% | 2,309 | +25.1% | 0.16% | +12.6% |
| Q4 2020 | $205,000 | – | 1,845 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |